UniProtKB/Swiss-Prot P33897 : Variant p.Gly266Arg
ATP-binding cassette sub-family D member 1
Gene: ABCD1
Feedback ?
Variant information
Variant position:
266
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glycine (G) to Arginine (R) at position 266 (G266R, p.Gly266Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from glycine (G) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In ALD.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
266
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
745
The length of the canonical sequence.
Location on the sequence:
IAGLVVFLTANVLRAFSPKF
G ELVAEEARRKGELRYMHSRV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human IAGLVVFLTANVLRAFSPKFG ELVAEEARRKGELRYMHSRV
Mouse IAGLVVFLTANVLRAFSPKFG ELVAEEARRKGELRYMHSRV
Rat IAGLVVFLTANVLRAFSPKFG ELVAEEARRKGELRYMHSRV
Zebrafish IAGIVVALTAKVLRAFSPRFG KLVAEEARRKGDLRYMHSRI
Drosophila SIG-VIALTAHILRIVSPKFG QLVSEEANRYGYLRHIHSRI
Slime mold VYG-FFFLGYLINKLVMSPMV SINYLQDKLEGDFRSLHQRI
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 745
ATP-binding cassette sub-family D member 1
Domain
94 – 386
ABC transmembrane type-1
Turn
265 – 267
Literature citations
Missense mutations are frequent in the gene for X-chromosomal adrenoleukodystrophy (ALD).
Fuchs S.; Sarde C.-O.; Wedemann H.; Schwinger E.; Mandel J.-L.; Gal A.;
Hum. Mol. Genet. 3:1903-1905(1994)
Cited for: VARIANTS ALD SER-148; ASP-174; ARG-266; GLN-401; TRP-418 AND PHE-515;
Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein.
Ligtenberg M.J.L.; Kemp S.; Sarde C.-O.; van Geel B.M.; Kleijer W.J.; Barth P.G.; Mandel J.-L.; van Oost B.A.; Bolhuis P.A.;
Am. J. Hum. Genet. 56:44-50(1995)
Cited for: VARIANTS ALD CYS-104; ASN-149; PRO-152; HIS-163; HIS-194; PRO-220; ARG-266; HIS-389; GLY-609; LYS-609; CYS-617 AND TRP-660;
Mutational analysis and genotype-phenotype correlation of 29 unrelated Japanese patients with X-linked adrenoleukodystrophy.
Takano H.; Koike R.; Onodera O.; Sasaki R.; Tsuji S.;
Arch. Neurol. 56:295-300(1999)
Cited for: VARIANTS ALD SER-148; ASN-200; ASP-214; ARG-266; LYS-271; CYS-296; TRP-401; VAL-507; GLN-518; SER-540; ARG-544; TRP-591; LEU-606 AND TRP-660;
X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism.
Wang Y.; Busin R.; Reeves C.; Bezman L.; Raymond G.; Toomer C.J.; Watkins P.A.; Snowden A.; Moser A.; Naidu S.; Bibat G.; Hewson S.; Tam K.; Clarke J.T.; Charnas L.; Stetten G.; Karczeski B.; Cutting G.; Steinberg S.;
Mol. Genet. Metab. 104:160-166(2011)
Cited for: VARIANTS ALD LEU-139 DEL; ARG-198; ARG-266; GLU-266; TRP-401; GLN-518; PHE-523; CYS-540; LEU-560; PRO-606; HIS-617; THR-626; PRO-632; ARG-633; LYS-640 AND ASP-677;
Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.
Matsukawa T.; Asheuer M.; Takahashi Y.; Goto J.; Suzuki Y.; Shimozawa N.; Takano H.; Onodera O.; Nishizawa M.; Aubourg P.; Tsuji S.;
Neurogenetics 12:41-50(2011)
Cited for: VARIANTS ALD LEU-108; SER-148; ASP-214; PRO-254; ARG-266; LYS-271; ARG-277; TRP-401; GLN-518; TRP-518; SER-540; ARG-544; LEU-560; LYS-609 AND TRP-660;
Genomic profiling identifies novel mutations and SNPs in ABCD1 gene: a molecular, biochemical and clinical analysis of X-ALD cases in India.
Kumar N.; Taneja K.K.; Kalra V.; Behari M.; Aneja S.; Bansal S.K.;
PLoS ONE 6:e25094-e25094(2011)
Cited for: VARIANTS ALD ARG-266; LYS-302; GLN-401; TRP-591; PRO-606; LYS-609 AND GLN-660;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.